Biopharma SPAC Jiya Acquisition priced its $100M IPO. The company intends to start trading today on the Nasdaq under the symbol “JYAC”. The company in earlier filings has said it may raise up to $25 million more at the closing of any merger under terms of a forward purchase agreement. Notice of effectiveness.
Related Posts
EVe Mobility Acquisition Registers for $200M IPO
EVe Mobility will target companies within the mobility-related ecosystem, included autonomous driving, connected and electric subsectors.
Venus Acquisition Arranges New $15M Backstop, Extends Merger Deadline on VIYI Algorithm Deal
As announced in June 2021, terms provide for a valuation of VIYI Algo and its subsidiaries and businesses of $400 million.
Aries II Acquisition Withdraws $130M IPO
Led by Thane Ritchie, Aries II had planned to apply for a Nasdaq listing with Oppenheimer & Co. serving as sole bookrunner.
PropTech II Upsizes IPO 15% to $200M
PropTech II plans to list on the Nasdaq under PTICU.